Federated Hermes, Inc. Chembio Diagnostics, Inc. Transaction History

Federated Hermes, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.35 - $1.1 $192 - $603	-549 Reduced 33.17%	1,106 $1,000
Q2 2022 Aug 15, 2022	BUY	$0.45 - $0.8 $118 - $210	263 Added 18.89%	1,655 $1,000
Q1 2022 May 13, 2022	BUY	$0.66 - $1.23 $858 - $1,600	1,301 Added 1429.67%	1,392 $1,000
Q4 2021 Feb 14, 2022	BUY	$1.09 - $2.55 $99 - $232	91 New	91 $1,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.